These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9636587)
21. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation. Rafecas A; Lladó L; Albiol MT; Ramos E; Torras J; Fabregat J; Lama C; Busquets J; Ibáñez L; Figueras J; Jaurrieta E Transplant Proc; 2002 Feb; 34(1):107. PubMed ID: 11959209 [No Abstract] [Full Text] [Related]
22. Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation. Maggi U; Rossi G; Vannelli A; Caccamo L; Gatti S; Paone G; Reggiani P; Melada E; Latham L; Andreani P; Fassati LR Transplant Proc; 1998 Dec; 30(8):3946-7. PubMed ID: 9865255 [No Abstract] [Full Text] [Related]
23. Combined orthotopic liver-small bowel transplantation or small bowel transplantation in pigs: relations between survival, rejection, and mucosal morphometry. Velio P; Bardella MT; Bertoglio ; Rossi G; Gatti S; Fassati LR Transplant Proc; 1997 May; 29(3):1840-1. PubMed ID: 9142295 [No Abstract] [Full Text] [Related]
24. Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Nevens F; Fevery J Transplant Proc; 2001; 33(1-2):1505. PubMed ID: 11267396 [No Abstract] [Full Text] [Related]
25. Does cyclosporine influence the outcome in patients with acute tubular necrosis after renal transplantation. Ritz M; Botha J; Pontin AR; Pascoe MD; Kahn D Transplant Proc; 1999; 31(1-2):303. PubMed ID: 10083117 [No Abstract] [Full Text] [Related]
26. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Schulak J; May E; Post A; Fasola C; Mulligan D; Sterling R Transplant Proc; 1997; 29(1-2):555-6. PubMed ID: 9123126 [No Abstract] [Full Text] [Related]
27. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
28. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588 [TBL] [Abstract][Full Text] [Related]
29. FK 506 rescue therapy: early conversion improves efficacy. Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359 [No Abstract] [Full Text] [Related]
30. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial. Gonzalez F; Espinoza M; Herrera P; Rocca X; Reynolds E; Lorca E; Roessler E; Hidalgo J; Espinoza O Transplant Proc; 2010; 42(1):270-2. PubMed ID: 20172327 [TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation. Lladó L; Figueras J; Ramos E; Lama C; Busquets J; Ibáñez L; Rafecas A; Fabregat J; Torras J; Jaurrieta E Transplant Proc; 2002 Feb; 34(1):108. PubMed ID: 11959210 [No Abstract] [Full Text] [Related]
32. Early steroid withdrawal after liver transplantation. Ramirez CB; Sebayel MI; Kizilisik T Transplant Proc; 1998 Nov; 30(7):3182-3. PubMed ID: 9838406 [No Abstract] [Full Text] [Related]
33. Cyclosporine monotherapy in long-term pediatric liver transplant recipients. Martin SR; Paradis K; Alvarez F Transplant Proc; 1998 Jun; 30(4):1424-6. PubMed ID: 9636577 [No Abstract] [Full Text] [Related]
34. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
35. Withdrawal of steroids from a cyclosporine-based regimen: pro. Ponticelli C Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281 [No Abstract] [Full Text] [Related]
36. Triple therapy with mycophenolate mofetil versus azathioprine. Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512 [No Abstract] [Full Text] [Related]
37. Triple therapy with cyclosporine A in kidney transplant patients. Matl I; Jirka J; Petrásek R; Vítko S Transplant Proc; 1995 Oct; 27(5):2573. PubMed ID: 7482831 [No Abstract] [Full Text] [Related]
38. Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation. Piazza A; Adorno D; Poggi E; Borrelli L; Buonomo O; Pisani F; Valeri M; Torlone N; Camplone C; Monaco PI; Fraboni D; Casciani CU Transplant Proc; 1998 Aug; 30(5):1769-71. PubMed ID: 9723274 [No Abstract] [Full Text] [Related]
39. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong. Lo CM; Fan ST; Liu CL; Chan KL; Ng IO; Lai CL; Lau GK; Fung SK; Wong J Transplant Proc; 1998 Nov; 30(7):3587-8. PubMed ID: 9838571 [No Abstract] [Full Text] [Related]
40. Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation. Otto G; Hofmann WJ; Gaweco AS; Seelos R; Herfarth C; Meuer S Transplant Proc; 1996 Dec; 28(6):3210-1. PubMed ID: 8962244 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]